普米克令舒与复方异丙托溴铵雾化吸入治疗哮喘性支气管炎的临床研究

Clinical Analysis on Pulmicort Combined With Combivent Atomization Inhalation in Treatment of Asthmatic Bronchitis

目的研究普米克令舒与复方异丙托溴铵雾化吸入治疗哮喘性支气管炎的疗效。方法研究对象为2016年1月-2016年11月本院哮喘性支气管炎患者总共73例,使用掷硬币法分组,对照组(35例)与研究组(38例)。对照组给予普米克令舒雾化吸入,而研究组给予普米克令舒与复方异丙托溴铵雾化吸入。治疗后对比两组的疗效。结果研究组患者的咳嗽消失、气喘消失及哮鸣音消失时间分别为(4.20±1.20)d、(3.47±1.63)d、(3.02±1.04)d,对照组患者的咳嗽消失、气喘消失及哮鸣音消失时间分别为(7.85±1.54)d、(5.59±1.59)d、(6.36±1.32)d,研究组患者的各项指标优于对照组,P<0.05,差异有统计学意义。结论哮喘性支气管炎采用普米克令舒与复方异丙托溴铵雾化吸入治疗,治疗效果好,患者病情症状改善快。

Objective To study the efficacy of probucol and probiotics in the treatment of asthma bronchitis. Methods From January 2016 to November 2016, 73 patients with asthmatic bronchitis were enrolled in the control group （n=35） and the study group （n=38）. The control group was given inhalation of pumicacol, and the study group was given pumicol and probenously inhaled. After treatment, the efficacy of the two groups were compared. Results The cough disappeared, the disappearance of asthma and the disappearance time of wheeze were （4.20±1.20） d, （3.47±1.63） d, （3.02±1.04） d, the cough disappeared and the asthma disappeared in the control group （7.85±1.54） d, （5.59±1.59） d, （6.36±1.32） d, the indexes of the study group were significantly better than the control group, the statistical treatment, P 〈0.05, there was difference statistically significant. Conclusion Asthmatic bronchitis is treated with pumicol and probenously inhaled, the treatment effect is good, the condition of the patient is improved quickly.